TR199901262T2 - Helicobacter pylori ve a��lar�. - Google Patents

Helicobacter pylori ve a��lar�.

Info

Publication number
TR199901262T2
TR199901262T2 TR1999/01262T TR9901262T TR199901262T2 TR 199901262 T2 TR199901262 T2 TR 199901262T2 TR 1999/01262 T TR1999/01262 T TR 1999/01262T TR 9901262 T TR9901262 T TR 9901262T TR 199901262 T2 TR199901262 T2 TR 199901262T2
Authority
TR
Turkey
Prior art keywords
pylori
lar
helicobacter pylori
preparations
polypeptides
Prior art date
Application number
TR1999/01262T
Other languages
Turkish (tr)
Inventor
Smith Douglas
A. Alm Richard
C. Doig Peter
Kabok Zita
Marie Catriotta Lillian
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of TR199901262T2 publication Critical patent/TR199901262T2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/205Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/106Vibrio; Campylobacter; Not used, see subgroups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Bu bulus tarif edildigi gibi bir araya getiren H. pylori ya da bunun önemli derecede saf müstahzarlari ile ilgilidir. Polipeptidleri kodlayan nükleik asitler de tarif edilmistir. H. pylori polipeptidleri teshis ve asi müstahzarlari için gereklidir ki buradaki sekil bes H. pylori proteininin bir amino asit dizisini göstermektedir.This invention relates to H. pylori, which combine as described, or substantially pure preparations thereof. Nucleic acids encoding polypeptides have also been described. H. pylori polypeptides are essential for diagnosis and rebellious preparations where the figure shows an amino acid sequence of the H. pylori protein.

TR1999/01262T 1996-12-05 1997-12-05 Helicobacter pylori ve a��lar�. TR199901262T2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75962596A 1996-12-05 1996-12-05
US82374597A 1997-03-25 1997-03-25
US89192897A 1997-07-14 1997-07-14

Publications (1)

Publication Number Publication Date
TR199901262T2 true TR199901262T2 (en) 1999-08-23

Family

ID=27419527

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01262T TR199901262T2 (en) 1996-12-05 1997-12-05 Helicobacter pylori ve a��lar�.

Country Status (18)

Country Link
EP (1) EP0964699A4 (en)
JP (1) JP2001510992A (en)
KR (1) KR20000069297A (en)
CN (1) CN1246799A (en)
AR (1) AR010337A1 (en)
AU (1) AU739641B2 (en)
BR (1) BR9714133A (en)
CA (1) CA2273199A1 (en)
EE (1) EE9900226A (en)
ID (1) ID21946A (en)
IL (1) IL129746A0 (en)
IS (1) IS5047A (en)
NO (1) NO992158L (en)
NZ (1) NZ335633A (en)
PL (1) PL333943A1 (en)
SK (1) SK57999A3 (en)
TR (1) TR199901262T2 (en)
WO (1) WO1998024475A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1197965C (en) * 1998-10-26 2005-04-20 诺维信公司 Constructing and screening a DNA library of interest in filamentous fungal cells
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AUPQ347199A0 (en) * 1999-10-15 1999-11-11 Csl Limited Novel polypeptide fragments
US6951729B1 (en) 1999-10-27 2005-10-04 Affinium Pharmaceuticals, Inc. High throughput screening method for biological agents affecting fatty acid biosynthesis
US7048926B2 (en) 2000-10-06 2006-05-23 Affinium Pharmaceuticals, Inc. Methods of agonizing and antagonizing FabK
AU2000277557A1 (en) * 2000-10-06 2002-04-22 Smith Kline Beecham Corporation Methods of agonizing and antagonizing fabk
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
US20120135039A1 (en) * 2008-10-08 2012-05-31 Aldwell Frank E Oral Vaccines for Producing Mucosal Immunity
WO2017102779A1 (en) * 2015-12-14 2017-06-22 Technische Universität München Helicobacter pylori vaccines
CN110343697A (en) * 2019-08-05 2019-10-18 湖州三零科技股份有限公司 A kind of plant disease fungus Total DNA extraction method
CN113435168B (en) * 2021-06-10 2024-03-22 上海美吉生物医药科技有限公司 Automatic editing method, system, terminal and medium for glue pattern
CN114057854B (en) * 2021-09-30 2022-07-15 河北医科大学第四医院 Helicobacter pylori CD4+T cell tolerance polypeptide fusion antigen and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300139L (en) * 1993-01-19 1994-07-20 Medicarb Ab Preparation of a new drug

Also Published As

Publication number Publication date
EP0964699A1 (en) 1999-12-22
KR20000069297A (en) 2000-11-25
SK57999A3 (en) 2000-05-16
AU5895498A (en) 1998-06-29
EE9900226A (en) 1999-12-15
AR010337A1 (en) 2000-06-07
CN1246799A (en) 2000-03-08
BR9714133A (en) 2000-02-29
PL333943A1 (en) 2000-01-31
AU739641B2 (en) 2001-10-18
NO992158D0 (en) 1999-05-04
IL129746A0 (en) 2000-02-29
NZ335633A (en) 2000-10-27
EP0964699A4 (en) 2005-04-06
WO1998024475A1 (en) 1998-06-11
CA2273199A1 (en) 1998-06-11
ID21946A (en) 1999-08-12
JP2001510992A (en) 2001-08-07
NO992158L (en) 1999-07-05
IS5047A (en) 1999-05-10

Similar Documents

Publication Publication Date Title
TR199901262T2 (en) Helicobacter pylori ve a��lar�.
DE60132075D1 (en) WNT-1 RELATED POLYPEPTIDES AND NUCLEIC ACIDS THEREFOR
TR200100163T2 (en) Hybrid polypeptides with enhanced pharmacokinetic properties
WO1998023639A3 (en) Shk toxin compositions and methods of use
WO2000034317A3 (en) Method for reducing immunogenicity of proteins
TR200200766T2 (en) Hybrid polypeptides with enhanced pharmacokinetic properties
ATE349700T1 (en) TRANSITION METAL COMPLEX CONTAINING LUMINESCENT PROTEIN COLORS
WO1999055132A3 (en) Generation of packaging system for human recombinant adenoviral vectors
AU5510286A (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor
TR199900940T2 (en) Nucleic and amino acid sequences of Helicobacter pylori.
ZA200007776B (en) Enzyme-protein complex.
TR199801939T2 (en) Nucleic acid and amino acid sequences and their network compositions related to Helicobacter pylori.
WO2000035950A3 (en) Reagents and methods useful for detecting diseases of the breast
NO20032818D0 (en) polypeptides
DE69931482D1 (en) ISOLATED PEPTIDES CORRESPOND TO THE AMINO ACID SEQUENCES OF NY-ESO-1 AND BIND MOLECULES AT MHC CLASS I AND MHC CLASS II, AND THEIR USES
DE948609T1 (en) POLYPEPTIDES COVERED BY HUMANEM LIPASE-LIKE GENE, COMPOSITIONS AND METHODS
CY2605B2 (en) Nucleotide sequence coding for a flavin-containingmonooxygenase, corresponding protein and their ap plications in the fields of diagnosis and therapy
WO1996040763A3 (en) Peptides for hiv-1 detection
TR199701538T1 (en) Nucleic acid and amino acid sequences of Helibacter pylorus.
CA2140091A1 (en) Peptides and antisera for detecting human cyclooxygenase-1 and cyclooxygenase-2
ATE267253T1 (en) PEPTIDES DERIVED FROM HTLV-I AND HTLV-II GP21 FOR DIAGNOSTIC USE
TR200003608T2 (en) BASB027 proteins and genes of Moraxella Catarrhalis.
NO982227D0 (en) Urogenital carcinoma-TPL complex peptides and antibodies thereof
BR0214567A (en) T cell epitopes in carboxypeptidase g2
WO2002010379A3 (en) Modified cea and uses thereof